UW Medicine-led ovarian cancer vaccine enters phase II trial: Healthlink

Summary
The UW Cancer Vaccine Institute is recruiting patients for a phase II clinical trial of an ovarian cancer vaccine that could stop cancer recurrence.
Description from KING-TV.
Who is covering this
-
UW Medicine-led ovarian cancer vaccine enters phase II trial: Healthlink
The UW Cancer Vaccine Institute is recruiting patients for a phase II clinical trial of an ovarian cancer vaccine that could stop cancer recurrence.
Comments
Comments need JavaScript.